AI-generated summary
The authors tested 660 nm light therapy on IL-1β-treated SW1353 cells, a cell model of osteoarthritis-like inflammation, and selected 5 mW/cm2 as the most consistent condition. They report that this treatment reduced IL6 and MMP13 expression and shifted many inflammation-related gene pathways in cells. Findings come from a cell model only, so they do not show effects in people.
- Who or what was studied
- SW1353 cells, a human chondrosarcoma-derived cell line used as an osteoarthritis-like cellular model treated with IL-1β
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study used a cell line rather than people or tissue, and the abstract does not report the number of replicate experiments or statistical details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 18 J/cm2
- Power density (irradiance)
- 5 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Osteoarthritis, Inflammation, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.